irbesartan &#160; ingelesa (Q947266)

DrugBank ^ingelesa

17 azaroa 2015

DrugBank ID ^ingelesa

01029

egitura kimikoa

Irbesartan polymorph A.svg
366 × 282; 30 KB

Erreferentzia bat

iturria

Alemanezko Wikipedia

masa

428,23246 masa atomikoaren unitate

Erreferentzia bat

138402-11-6 (ingelesa)

4 urria 2016

formula kimikoa

C₂₅H₂₈N₆O

Erreferentzia bat

138402-11-6 (ingelesa)

19 azaroa 2016

SMILES

CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5

Erreferentzia bat

138402-11-6 (ingelesa)

19 azaroa 2016

defined daily dose ^ingelesa

0,15 gramo

route of administration ^ingelesa

aho emate

Erreferentzia bat

https://www.whocc.no/atc_ddd_index/?code=C09CA04

active ingredient in ^ingelesa

Aprovel ^ingelesa

Erreferentzia bat

EMEA/H/C/000141

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000141/human_med_000649.jsp

22 martxoa 2017

Irbesartan Bms ^ingelesa

Erreferentzia bat

EMEA/H/C/000786

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000786/human_med_000851.jsp

22 martxoa 2017

Irbesartan Teva ^ingelesa

Erreferentzia bat

EMEA/H/C/001093

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001093/human_med_000855.jsp

22 martxoa 2017

Irbesartan Zentiva ^ingelesa

Erreferentzia bat

EMEA/H/C/000785

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000785/human_med_000856.jsp

22 martxoa 2017

Karvea ^ingelesa

Erreferentzia bat

EMEA/H/C/000142

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000142/human_med_000868.jsp

22 martxoa 2017

Sabervel ^ingelesa

Erreferentzia bat

EMEA/H/C/002510

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002510/human_med_001556.jsp

22 martxoa 2017

Avapro ^ingelesa

Erreferentzia bat

RxNorm ^ingelesa

RxNorm ID ^ingelesa

153668

14 otsaila 2018

World Health Organisation international non-proprietary name ^ingelesa

irbesartan (ingelesa)

Erreferentzia bat

ChEBI ^ingelesa

irbesartan (ingelesa)

4 urria 2016

medical condition treated ^ingelesa

hipertentsio

2 erreferentzia

NDF-RT ^ingelesa

NDF-RT ID ^ingelesa

N0000148533

13 abendua 2016

Drug Indications Extracted from FAERS ^ingelesa

2 urria 2018

significant drug interaction ^ingelesa

lisinopril dihydrate ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

quinapril ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

trandolapril ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

fosinopril ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

perindopril ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

lisinopril dihydrate ^ingelesa

side effect ^ingelesa

hyperkalemia ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

quinapril ^ingelesa

side effect ^ingelesa

hyperkalemia ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

side effect ^ingelesa

hyperkalemia ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

side effect ^ingelesa

hyperkalemia ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

side effect ^ingelesa

hyperkalemia ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

trandolapril ^ingelesa

side effect ^ingelesa

hyperkalemia ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

perindopril ^ingelesa

side effect ^ingelesa

hyperkalemia ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Trimetoprima

side effect ^ingelesa

hyperkalemia ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

triamterene ^ingelesa

side effect ^ingelesa

hyperkalemia ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

amiloride ^ingelesa

side effect ^ingelesa

hyperkalemia ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

eplerenone ^ingelesa

side effect ^ingelesa

hyperkalemia ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Espironolaktona

side effect ^ingelesa

hyperkalemia ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

nabumetone ^ingelesa

side effect ^ingelesa

hyperkalemia ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Naproxeno

side effect ^ingelesa

hyperkalemia ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

celecoxib ^ingelesa

side effect ^ingelesa

hyperkalemia ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

diklofenako

side effect ^ingelesa

hyperkalemia ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Piroxicam

side effect ^ingelesa

hyperkalemia ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

meloxicam ^ingelesa

side effect ^ingelesa

hyperkalemia ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

(RS)-fenoprofen ^ingelesa

side effect ^ingelesa

hyperkalemia ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

(+-)-flurbiprofen ^ingelesa

side effect ^ingelesa

hyperkalemia ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Ibuprofeno

side effect ^ingelesa

hyperkalemia ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

indomethacin ^ingelesa

side effect ^ingelesa

hyperkalemia ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

(RS)-ketoprofen ^ingelesa

side effect ^ingelesa

hyperkalemia ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

(RS)-etodolac ^ingelesa

side effect ^ingelesa

hyperkalemia ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

sulindac ^ingelesa

side effect ^ingelesa

hyperkalemia ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

parecoxib ^ingelesa

side effect ^ingelesa

hyperkalemia ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

tenoxicam ^ingelesa

side effect ^ingelesa

hyperkalemia ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

eplerenone ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Espironolaktona

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

nabumetone ^ingelesa

side effect ^ingelesa

increased systemic arterial blood pressure ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

nabumetone ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Naproxeno

side effect ^ingelesa

increased systemic arterial blood pressure ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Naproxeno

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

celecoxib ^ingelesa

side effect ^ingelesa

increased systemic arterial blood pressure ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

celecoxib ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

diklofenako

side effect ^ingelesa

increased systemic arterial blood pressure ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

diklofenako

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Piroxicam

side effect ^ingelesa

increased systemic arterial blood pressure ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Piroxicam

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

meloxicam ^ingelesa

side effect ^ingelesa

increased systemic arterial blood pressure ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

meloxicam ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

(RS)-fenoprofen ^ingelesa

side effect ^ingelesa

increased systemic arterial blood pressure ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

(RS)-fenoprofen ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

(+-)-flurbiprofen ^ingelesa

side effect ^ingelesa

increased systemic arterial blood pressure ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

(+-)-flurbiprofen ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Ibuprofeno

side effect ^ingelesa

increased systemic arterial blood pressure ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Ibuprofeno

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

indomethacin ^ingelesa

side effect ^ingelesa

increased systemic arterial blood pressure ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

indomethacin ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

(RS)-ketoprofen ^ingelesa

side effect ^ingelesa

increased systemic arterial blood pressure ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

(RS)-ketoprofen ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

(RS)-etodolac ^ingelesa

side effect ^ingelesa

increased systemic arterial blood pressure ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

(RS)-etodolac ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

sulindac ^ingelesa

side effect ^ingelesa

increased systemic arterial blood pressure ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

sulindac ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

parecoxib ^ingelesa

side effect ^ingelesa

increased systemic arterial blood pressure ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

parecoxib ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

tenoxicam ^ingelesa

side effect ^ingelesa

increased systemic arterial blood pressure ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

tenoxicam ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

lisinopril dihydrate ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

lisinopril dihydrate ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

lisinopril dihydrate ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

quinapril ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

quinapril ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

quinapril ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

trandolapril ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

trandolapril ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

trandolapril ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

fosinopril ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

fosinopril ^ingelesa

side effect ^ingelesa

hyperkalemia ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

fosinopril ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

fosinopril ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

perindopril ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

perindopril ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

perindopril ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

fisikoki honekin elkarrekintza du

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Angiotensin II receptor type 1 ^ingelesa

subjektuak duen rola

antagonist ^ingelesa

Erreferentzia bat

17 abuztua 2016

Solute carrier family 10 member 1 ^ingelesa

subjektuak duen rola

antagonist ^ingelesa

Erreferentzia bat

17 abuztua 2016

legal status (medicine) ^ingelesa

boxed warning ^ingelesa

Erreferentzia bat

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (ingelesa)

pregnancy category ^ingelesa

Australian pregnancy category D ^ingelesa

Erreferentzia bat

iturria

Ingelesezko Wikipedia

LiverTox likelihood score ^ingelesa

LiverTox toxicity likelihood category C ^ingelesa

Erreferentzia bat

LiverTox ^ingelesa

8 apirila 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Irbesartan

azken eguneraketa

13 urtarrila 2017

subjektuak duen rola

angiotensin II receptor antagonist ^ingelesa

Erreferentzia bat

Medical Subject Headings

MeSH identifikadorea

C081309

15 martxoa 2018

antihypertensive drug ^ingelesa

Erreferentzia bat

Medical Subject Headings

MeSH identifikadorea

C081309

InChI=1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30)

15 martxoa 2018

Commons-eko kategoria

Irbesartan

0 erreferentzia

Identifikatzaileak

InChI

Erreferentzia bat

138402-11-6 (ingelesa)

19 azaroa 2016

2 erreferentzia

138402-11-6 (ingelesa)

19 azaroa 2016

ChEBI release 2020-09-01 ^ingelesa

CAS zenbakia

138402-11-6

2 erreferentzia

irbesartan (ingelesa)

19 azaroa 2016

CAS Common Chemistry ^ingelesa

10 apirila 2021

https://commonchemistry.cas.org/detail?cas_rn=138402-11-6

ChemSpider-ren identifikatzailea

3618

Erreferentzia bat

ChemSpider-ren identifikatzailea

ChemSpider ^ingelesa

3618

Irbesartan (ingelesa)

19 azaroa 2016

2 erreferentzia

138402-11-6 (ingelesa)

19 azaroa 2016

InChIKey ^ingelesa

Reaxys registry number ^ingelesa

6620400

Erreferentzia bat

ChEBI ^ingelesa

irbesartan (ingelesa)

4 urria 2016

mapping relation type ^ingelesa

exact match ^ingelesa

2 erreferentzia

ChEMBL-en identifikatzailea

ChEMBL ^ingelesa

CHEMBL1513

IRBESARTAN (ingelesa)

19 azaroa 2016

InChI=1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30)

International Chemical Identifier ^ingelesa

InChI

ChEMBL-en identifikatzailea

CHEMBL1513

Erreferentzia bat

ChEMBL-en identifikatzailea

ChEMBL ^ingelesa

CHEMBL1513

IRBESARTAN (ingelesa)

19 azaroa 2016

SureChEMBL ID ^ingelesa

SCHEMBL4246

2 erreferentzia

based on heuristic ^ingelesa

inferred from InChIKey ^ingelesa

InChIKey ^ingelesa

SCHEMBL285754

2 erreferentzia

based on heuristic ^ingelesa

inferred from InChIKey ^ingelesa

InChIKey ^ingelesa

UniChem compound ID ^ingelesa

209618

Erreferentzia bat

MSBNK-Athens_Univ-AU209402

UniChem ^ingelesa

MassBank accession ID ^ingelesa

SM818701

0 erreferentzia

SM818756

0 erreferentzia

0 erreferentzia

MSBNK-Athens_Univ-AU209403

0 erreferentzia

MSBNK-Athens_Univ-AU209404

0 erreferentzia

MSBNK-Athens_Univ-AU209405

0 erreferentzia

MSBNK-Athens_Univ-AU209407

0 erreferentzia

MSBNK-Athens_Univ-AU209408

0 erreferentzia

MSBNK-Athens_Univ-AU209409

0 erreferentzia

MSBNK-Athens_Univ-AU209410

0 erreferentzia

MSBNK-Athens_Univ-AU209411

0 erreferentzia

MSBNK-Athens_Univ-AU209451

0 erreferentzia

MSBNK-Athens_Univ-AU209452

0 erreferentzia

MSBNK-Athens_Univ-AU209453

0 erreferentzia

MSBNK-Athens_Univ-AU209454

0 erreferentzia

MSBNK-Athens_Univ-AU209455

0 erreferentzia

0 erreferentzia

0 erreferentzia

0 erreferentzia

0 erreferentzia

0 erreferentzia

0 erreferentzia

0 erreferentzia

0 erreferentzia

0 erreferentzia

0 erreferentzia

0 erreferentzia

0 erreferentzia

0 erreferentzia

0 erreferentzia

0 erreferentzia

0 erreferentzia

0 erreferentzia

0 erreferentzia

0 erreferentzia

0 erreferentzia

0 erreferentzia

0 erreferentzia

0 erreferentzia

0 erreferentzia

0 erreferentzia

0 erreferentzia

0 erreferentzia

0 erreferentzia

0 erreferentzia

0 erreferentzia

0 erreferentzia

0 erreferentzia

MSBNK-Waters-WA001036

0 erreferentzia

MSBNK-Waters-WA001037

0 erreferentzia

MSBNK-Waters-WA001038

0 erreferentzia

MSBNK-Waters-WA001039

0 erreferentzia

MSBNK-Waters-WA001040

0 erreferentzia

MSBNK-Waters-WA001041

0 erreferentzia

MSBNK-Waters-WA001042

0 erreferentzia

SPLASH ^ingelesa

splash10-0a4i-0190000000-97e745948e54828d3cb9

0 erreferentzia

splash10-0a4i-0190000000-da94b482f79a90e5784c

0 erreferentzia

splash10-0a4i-0590000000-122d562d8d5352dd2a88

0 erreferentzia

splash10-004i-0000900000-b6619e18dca63147588d

0 erreferentzia

splash10-004l-0801900000-b884691a3577ffab749f

0 erreferentzia

splash10-0006-0900000000-130056acf88b6caed131

0 erreferentzia

splash10-0006-0900000000-97919ed4377a869dc8cc

0 erreferentzia

splash10-0006-0900000000-55cf0ae2c686af5c38e3

0 erreferentzia

splash10-0a4i-0290100000-e3c8e0950f0290ccefdc

0 erreferentzia

splash10-004i-0000900000-61da6c552b6d170d8283

0 erreferentzia

splash10-0a4i-0290100000-0e7bf8c50467ae6a7604

0 erreferentzia

splash10-0a4i-0290000000-21c875faccf2cb3a15b3

0 erreferentzia

splash10-0a4i-0490000000-e7c75f4866b7b9f0d0e8

0 erreferentzia

splash10-0a59-1960000000-a6601ea10b0fe87e6c0a

0 erreferentzia

splash10-0a5c-0920000000-d7f5d3920f8586eac33f

0 erreferentzia

splash10-004i-0000900000-57215a52cacf3c9ede5c

0 erreferentzia

splash10-0a4i-0290100000-29a34a51d9b42976905f

0 erreferentzia

splash10-0a4i-0290000000-e6e7f5d1e696ec43651d

0 erreferentzia

splash10-0a4i-1690000000-217de4040066a20fd367

0 erreferentzia

splash10-0a59-1950000000-ac722925e6b2aa2930fb

0 erreferentzia

splash10-0a5c-0930000000-0b8d8a97e3db30de0e21

0 erreferentzia

splash10-0a4i-0290100000-ee3d21bc8110bf939cdd

0 erreferentzia

splash10-0007-0908000000-0c994ee86857e7d63e48

0 erreferentzia

splash10-004i-0000900000-b610a12a9852ff1a11c1

0 erreferentzia

splash10-0006-0900100000-c9024d0b00a0ec781fa2

0 erreferentzia

splash10-0006-0900000000-cb54b7c0917d67313110

0 erreferentzia

splash10-0006-0900000000-4e0d1ebbc0609ecaa59d

0 erreferentzia

splash10-0006-0900000000-ec0fc575bb22a99c258d

0 erreferentzia

splash10-00di-0900000000-f1f0658a24e5097674e0

0 erreferentzia

splash10-004i-0000900000-12da76073bae1768b7e2

0 erreferentzia

splash10-0006-0900000000-cce4e6a8c5bbaa66c902

0 erreferentzia

splash10-0006-0900000000-c7202e4de31fc762cf2d

0 erreferentzia

splash10-0006-0900000000-ad31324f1b1a0e9be0b8

0 erreferentzia

splash10-0006-0900000000-2301c02c521c3dab9c79

0 erreferentzia

splash10-00di-0900000000-8b6e9e772c5af1365e87

0 erreferentzia

splash10-0007-0908000000-97706153fba817a654e4

0 erreferentzia

splash10-0a59-2791700000-a5bc1c8b020f7731fb1e

0 erreferentzia

splash10-0a6r-0490500000-2693358cc0b819b773a5

0 erreferentzia

splash10-002f-0900400000-f9f11306595c7a9de207

0 erreferentzia

HSDB ID ^ingelesa

8215

Erreferentzia bat

Hazardous Substances Data Bank ^ingelesa

HSDB ID ^ingelesa

8215

28 urria 2019

Irbesartan (ingelesa)

10 maiatza 2021

DSSTox substance ID ^ingelesa

DTXSID0023169

2 erreferentzia

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard ^ingelesa

InChIKey ^ingelesa

DSSTOX compound identifier ^ingelesa

DTXCID903169

0 erreferentzia

LiverTox ID ^ingelesa

Irbesartan

0 erreferentzia

NSC number ^ingelesa

758696

0 erreferentzia

EC zenbakia

604-078-2

Erreferentzia bat

ECHA Substance Infocard database ^ingelesa

ECHA Substance Infocard ID ^ingelesa

100.119.966

27 abendua 2018

2-butyl-3-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1,3-diazaspiro[4.4]non-1-en-4-one (ingelesa)

quotation ^ingelesa

CAS no.: 138402-11-6 (ingelesa)

ECHA Substance Infocard ID ^ingelesa

100.119.966

Erreferentzia bat

ECHA Substance Infocard database ^ingelesa

ECHA Substance Infocard ID ^ingelesa

100.119.966

27 abendua 2018

2-butyl-3-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1,3-diazaspiro[4.4]non-1-en-4-one (ingelesa)

quotation ^ingelesa

CAS no.: 138402-11-6 (ingelesa)

ATC kodea

C09CA04

Erreferentzia bat

DrugBank ^ingelesa

DrugBank ID ^ingelesa

01029

Irbesartan (ingelesa)

17 azaroa 2015

Erreferentzia bat

irbesartan (ingelesa)

19 azaroa 2016

6908

Erreferentzia bat

D02.455.426.559.389.185.413

5 otsaila 2021

Irbesartan

0 erreferentzia

MeSH kodea

0 erreferentzia

D02.455.426.779.431

0 erreferentzia

D03.383.129.617.351

0 erreferentzia

D04.711.431

0 erreferentzia

RxNorm ID ^ingelesa

83818

Erreferentzia bat

irbesartan (ingelesa)

19 azaroa 2016

DrugBank ID ^ingelesa

DB01029

Erreferentzia bat

InChIKey ^ingelesa

Human Metabolome Database ID ^ingelesa

HMDB0015163

2 erreferentzia

based on heuristic ^ingelesa

inferred from InChIKey ^ingelesa

InChIKey ^ingelesa

2 erreferentzia

irbesartan (ingelesa)

19 azaroa 2016

InChIKey ^ingelesa

MedlinePlus drug identifier ^ingelesa

a698009

0 erreferentzia

PatientsLikeMe treatment ID ^ingelesa

irbesartan

0 erreferentzia

NDF-RT ID ^ingelesa

N0000148533

Erreferentzia bat

irbesartan (ingelesa)

19 azaroa 2016

Probes And Drugs ID ^ingelesa

PD001208

0 erreferentzia

DrugCentral ID ^ingelesa

1481

Erreferentzia bat

KEGG-ren identifikatzailea

UniChem ^ingelesa

C07469

Erreferentzia bat

ChEBI ^ingelesa

irbesartan (ingelesa)

4 urria 2016

D00523

Erreferentzia bat

ChEBI ^ingelesa

irbesartan (ingelesa)

Freebase-ren identifikatzailea

4 urria 2016

DeCS ID ^ingelesa

57633

0 erreferentzia

/m/038t69

Erreferentzia bat

Freebase Data Dumps ^ingelesa

Microsoft Academic identifikatzailea

28 urria 2013

0 erreferentzia

Erreferentzia bat

26 urtarrila 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

UMLS CUI ^ingelesa

C0288171

Erreferentzia bat

irbesartan (ingelesa)